Align Technology, Inc. (NQ: ALGN)
36.70 USD  -0.28 (-0.76%)
Official Closing Price  /  Updated: 5:20 PM EDT, May 24, 2013  /  Add to My Watchlist      
Align Technology, Inc. Community Page | What other sites are saying about Align Technology, Inc.
(ALGN) Community Analysis from
May 24, 2013
(Stock Blog Hub, 11/12/12)
A major player in the malocclusion market, Align Technology’s (ALGN) shares plunged 7.47% to close at $35.41 yesterday, following the release of its...(read more)
(Stock Blog Hub, 10/2/12)
Align Technology, Inc. (ALGN) reported a strong second quarter with both revenues and earnings sailing past the Zacks Consensus Estimates, on the back of its flagship product,...(read more)
(Samurai Trader, 9/6/12)
There were a bunch of breakouts on the leadership list today, and I was thinking of avoiding them since I will probably be looking at them this weekend, but ALGN is too good to pass up. Not today's breakout: the good...(read more)
Align Technology (ALGN) Company Overview

Align Technology, Inc., founded in 1997, is engaged in the design, manufacture, and marketing of Invisalign, a proprietary system for treating malocclusion, or crooked teeth. The Invisalign product has two components, ClinCheck and Aligners. ClinCheck is an Internet-based application that allows dental professionals to simulate treatment in three dimensions, by modeling two-week stages of tooth movement. Aligners are thin, clear-plastic, removable dental appliances that are manufactured in a series to correspond to each two-week stage of the ClinCheck simulation. Aligners are customized to perform the treatment prescribed for an individual patient by dental professionals using ClinCheck. Invisalign is approved to treat patients, with any type of malocclusion, with mature upper and lower tooth structures. The company voluntarily restricts the use of Invisalign to adults and adolescents with immature structures. Typically, permanent structures occur in the later-teen years. Align does not treat children whose teeth and jaws are still developing, as the effectiveness of Invisalign relies on the company's ability to accurately predict the movement of teeth over the course of treatment. Based on its clinical studies to date, Align recommends that dental professionals use Invisalign as a complete treatment for a range of malocclusions, and as a component of treatment for severe malocclusions.


(Read more at Wikinvest )

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here